Unlock stock picks and a broker-level newsfeed that powers Wall Street.
NYSE - Delayed Quote USD

Encompass Health Corporation (EHC)

Compare
100.78
-0.36
(-0.36%)
At close: March 28 at 4:00:02 PM EDT
100.78
0.00
(0.00%)
After hours: March 28 at 6:20:36 PM EDT
Loading Chart for EHC
  • Previous Close 101.14
  • Open 101.38
  • Bid --
  • Ask --
  • Day's Range 100.06 - 101.80
  • 52 Week Range 78.53 - 104.55
  • Volume 457,600
  • Avg. Volume 682,040
  • Market Cap (intraday) 10.149B
  • Beta (5Y Monthly) 0.83
  • PE Ratio (TTM) 22.45
  • EPS (TTM) 4.49
  • Earnings Date Apr 22, 2025 - Apr 28, 2025
  • Forward Dividend & Yield 0.68 (0.67%)
  • Ex-Dividend Date Apr 1, 2025
  • 1y Target Est 117.25

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions. It offers services through the Medicare program to federal government, managed care plans and private insurers, state governments, and other patients. The company was formerly known as HealthSouth Corporation and changed its name to Encompass Health Corporation in January 2018. Encompass Health Corporation was incorporated in 1984 and is based in Birmingham, Alabama.

www.encompasshealth.com

23,564

Full Time Employees

December 31

Fiscal Year Ends

Recent News: EHC

View More

Performance Overview: EHC

Trailing total returns as of 3/28/2025, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .

YTD Return

EHC
9.33%
S&P 500 (^GSPC)
5.11%

1-Year Return

EHC
22.69%
S&P 500 (^GSPC)
6.22%

3-Year Return

EHC
89.00%
S&P 500 (^GSPC)
21.97%

5-Year Return

EHC
122.42%
S&P 500 (^GSPC)
119.59%

Compare To: EHC

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: EHC

View More

Valuation Measures

Annual
As of 3/28/2025
  • Market Cap

    10.15B

  • Enterprise Value

    12.78B

  • Trailing P/E

    22.45

  • Forward P/E

    20.70

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    1.92

  • Price/Book (mrq)

    4.91

  • Enterprise Value/Revenue

    2.38

  • Enterprise Value/EBITDA

    10.77

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    8.48%

  • Return on Assets (ttm)

    8.65%

  • Return on Equity (ttm)

    23.29%

  • Revenue (ttm)

    5.37B

  • Net Income Avi to Common (ttm)

    455.7M

  • Diluted EPS (ttm)

    4.49

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    85.4M

  • Total Debt/Equity (mrq)

    95.25%

  • Levered Free Cash Flow (ttm)

    215.84M

Research Analysis: EHC

View More

Company Insights: EHC

Research Reports: EHC

View More

People Also Watch